Sequence-dependent growth inhibition and DNA damage formation by the irinotecan–5-fluorouracil combination in human colon carcinoma cell lines
- 1 December 1999
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (13) , 1851-1861
- https://doi.org/10.1016/s0959-8049(99)00222-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- CPT-11 in human colon-cancer cell lines and xenografts: Characterization of cellular sensitivity determinantsInternational Journal of Cancer, 1997
- Clinical highlights from the National Cancer Data Base: 1996CA: A Cancer Journal for Clinicians, 1996
- Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidinesAnnals of Oncology, 1996
- ZD1694 (Tomudex): A new thymidylate synthase inhibitor with activity in colorectal cancerEuropean Journal Of Cancer, 1995
- Comparison of Topoisomerase I Inhibition, DNA Damage, and Cytotoxicity of Camptothecin Derivatives Presently in Clinical TrialsJNCI Journal of the National Cancer Institute, 1994
- Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.Journal of Clinical Oncology, 1993
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Clinical relevance of biochemical modulation of 5-fluorouracilAnnals of Oncology, 1991
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylateBiochemistry, 1974